Everything, as it turns out. There’s a law in South Africa which states that if an insurance company is granted the right to sell a health-related product, it must get the approval of the Council for Medical Schemes (CMS) before making any substantial changes to that product – including changing its name. Which is why Dis-Chem and its medical insurance partner, Centriq, now find themselves in a spot of bother over the naming of the health insurance products they have partnered on. In a classic case of ‘white labelling’ (or basically private labelling), the word ‘Dis-Chem’ was placed in front of Centriq’s existing ‘MyHealth Core’ and ‘MyHealth Vital’ products and marketed through and by Dis-Chem to its customer base. White labelling, although not illegal, follows very strict rules when it comes to pharmaceuticals and other health products. The CMS argued that by adding ‘Dis-Chem’ to the name, Centriq effectively created a new product name, for which it did not ask permission, and that customers might think Dis-Chem was the actual insurer. Centriq appealed against the decision, which the Appeals Board overruled. Centriq is currently engaging with the regulator to fix the paperwork and has already started stripping ‘Dis-Chem’ off the product names, as can be seen on the Dis-Chem website. “We do not anticipate a material impact on our policyholders and will continue to cooperate and work with CMS going forward,” says Centriq.
Dis-Chem
What’s in a name?
Source: Moonstone.co.za 15/01/26
Ti Perspective: The CMS has the power to shut the partnership down if its rules are not followed exactly, which in this case would leave thousands of people without health insurance – and nobody wants that. Fingers crossed the matter can be resolved swiftly for the good of all stakeholders concerned.


